Similar articles

• [Use of alpha-interferon in the treatment of hairy-cell leukemia].

  Pagnucco G, Castelli G, Lazzarino M, Bernasconi C. Pagnucco G, et al. Haematologica. 1990 Jul-Aug;75 Suppl 4:56-67. Haematologica. 1990. PMID: 2074056 Review. Italian. No abstract available.
• Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.

  Goldaniga M, Guffanti A, Gianelli U, Magni M, Lambertenghi Deliliers G, Baldini L. Goldaniga M, et al. Haematologica. 2004 Nov;89(11):ECR41. Haematologica. 2004. PMID: 15533846 No abstract available.
• [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].

  Gotić M, Rolović Z, Radosević N, Draguljac N, Jovanović V, Bogdanović A, Bosković D. Gotić M, et al. Srp Arh Celok Lek. 2000 Jul-Aug;128(7-8):262-70. Srp Arh Celok Lek. 2000. PMID: 11089434 Serbian.
• Hairy-cell leukemia and the surgeon.

  Eldar S, Abrahamson J. Eldar S, et al. Curr Surg. 1986 Nov-Dec;43(6):466-9. Curr Surg. 1986. PMID: 2433096 No abstract available.
• [Evidence-based therapy for adult T-cell leukemia and the related leukemias].

  Matsuoka M. Matsuoka M. Nihon Naika Gakkai Zasshi. 2003 Jun 10;92(6):986-91. Nihon Naika Gakkai Zasshi. 2003. PMID: 12866443 Review. Japanese. No abstract available.